Crumly & Associates’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Other funds holding BSX
ATO
RG
YIH
FFM
ZIC
Crumly & Associates's BSX Position: Q2 2026 in Review
Crumly & Associates reduced its Boston Scientific (BSX) stake by 5.9% in Q2 2026, selling an estimated $16.9K and leaving 4,991 shares worth $213K. The position accounts for 0.04% of the portfolio, ranked #187.
Crumly & Associates first reported a position in BSX in Q4 2022 and has held it in 15 quarters since. The position peaked at $803K in Q4 2024. 303 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- Crumly & Associates held 4,991 shares of Boston Scientific worth $213K as of Q2 2026.
- Crumly & Associates sold 312 Boston Scientific shares in Q2 2026, an estimated $16.9K.
- Boston Scientific made up 0.04% of Crumly & Associates's portfolio in Q2 2026, its #187 holding.
- Crumly & Associates first reported a position in Boston Scientific in Q4 2022 and has held it in 15 quarters since.
- Crumly & Associates's Boston Scientific position peaked at $803K in Q4 2024.
- 303 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on Crumly & Associates's 13F filing for Q2 2026, filed 8 Jul 2026.